Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity (original) (raw)
Abstract.
The use of fusions between dendritic cells (DCs) and tumor cells as vaccines has been proved very effective in stimulating antitumor immune responses, both in animal studies and in early human clinical trials. Because of the difficulty of purifying the hybrid cells from the fusion, fusion mixtures were used in these studies. Recently, we developed a technique using fluorescent-dye staining and fluorescence-activated cell sorting that enabled the hybrid cells to be instantly purified from the fusion mixture [10]. In the present study, the hybrid cells were purified from a fusion between mouse DCs and B16F0 melanoma tumor cells using the new technique. The purified cells, named instant dendritomas (IDs) were then compared with fusion mixtures in stimulating antitumor immune responses. The results from cytotoxicity assays, interferon-γ production and in vivo lung tumor metastasis demonstrated that IDs are more effective than fusion mixture in stimulating antitumor immunity. Meanwhile, there was no significant difference in the antitumor immunities activated by IDs from allogenic fusion or IDs from syngenic fusion.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime Subscribe now
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
- Oncology Research Institute, Greenville Hospital System, 900 W. Faris Road, Greenville, SC 29605, USA, , , , ,
J. Li, L. Holmes, K. Burgin, T. Wagner & Y. Wei - Department of Microbiology and Molecular Medicine, Clemson University, Clemson, South Carolina, USA, , , , ,
K. Franek
Authors
- J. Li
You can also search for this author inPubMed Google Scholar - L. Holmes
You can also search for this author inPubMed Google Scholar - K. Franek
You can also search for this author inPubMed Google Scholar - K. Burgin
You can also search for this author inPubMed Google Scholar - T. Wagner
You can also search for this author inPubMed Google Scholar - Y. Wei
You can also search for this author inPubMed Google Scholar
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Li, .J., Holmes, .L., Franek, .K. et al. Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity.Cancer Immunol Immunother 50, 456–462 (2001). https://doi.org/10.1007/s002620100218
- Received: 09 May 2001
- Accepted: 28 June 2001
- Issue Date: November 2001
- DOI: https://doi.org/10.1007/s002620100218